Companies similar to Novo Nordisk for Financial Business Analyst
Company name | Avg Annual Salary | Open Jobs |
---|---|---|
![]() AstraZeneca Financial Business Analyst Salary
6 - 9 years exp. (4 salaries) | ₹8.5 L/yr - ₹15 L/yr | 1 job opening |
![]() Agilent Technologies Financial Business Analyst Salary
4 - 8 years exp. (4 salaries) | ₹8.1 L/yr - ₹17.6 L/yr | |
Login to view exact salary
| ||
![]() IBM Financial Business Analyst Salary
0 - 6 years exp. (62 salaries) | ₹2.1 L/yr - ₹7 L/yr | |
![]() TCS Financial Business Analyst Salary
1 - 15 years exp. (52 salaries) | ₹5 L/yr - ₹20 L/yr | |
![]() Flipkart Financial Business Analyst Salary
0 - 4 years exp. (39 salaries) | ₹6 L/yr - ₹23 L/yr | |
Experience wise Novo Nordisk Financial Business Analyst salaries
Last Updated: 14 Mar 2023
Experience | Avg Annual Salary |
---|---|
8 years (AmbitionBox Estimate) |
₹11.3
L/yr
- ₹13.4
L/yr
|
9 years (AmbitionBox Estimate) |
₹4.3
L/yr
- ₹11.3
L/yr
|
Login to view exact salary
| |
10 years (AmbitionBox Estimate) |
₹8.7
L/yr
- ₹16.2
L/yr
|
Similar Designation salaries in Novo Nordisk
Salary related reviews for Novo Nordisk
Discover interview dos and don'ts from real experiences
Top trending discussions







Novo Nordisk Financial Business Analyst Salary FAQs
- Flipkart Financial Business Analyst Salary - ₹6.0 Lakhs to ₹23.0 Lakhs per year
- AstraZeneca Financial Business Analyst Salary - ₹8.5 Lakhs to ₹15.0 Lakhs per year
- Agilent Technologies Financial Business Analyst Salary - ₹8.1 Lakhs to ₹17.6 Lakhs per year
- TCS Financial Business Analyst Salary - ₹5.0 Lakhs to ₹20.0 Lakhs per year
- IBM Financial Business Analyst Salary - ₹2.1 Lakhs to ₹7.0 Lakhs per year
Tell us how to improve this page.
- Home >
- Salaries >
- Novo Nordisk Salaries >
- Novo Nordisk Financial Business Analyst Salaries
Novo Nordisk Financial Business Analyst salary
in
India
ranges between ₹8.7
Lakhs to ₹13.4
Lakhs with an average annual salary of
₹. Salary estimates are based on
4
Novo Nordisk latest salaries received from various employees of
Novo Nordisk.